Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

R. Mark Ghobrial, M.D., Ph.D., F.A.C.S., F.R.C.S. (Ed)

R. Mark Ghobrial, M.D., Ph.D., F.A.C.S., F.R.C.S. (Ed)

Dr. R. Mark Ghobrial

Media Contact:

George Kovacik
832-667-5844
ggkovacik@houstonmethodist.org

Director/Chief of Liver Transplantation Surgery
Methodist Center for Liver Disease & Transplantation
Director/Immunobiology Research Center

Clinical Interests

  • Liver transplantation surgery
  • Hepatobiliary surgery
  • Pancreas transplant surgery

Research Interests

  • Pre-transplant variables associated with quality of life in liver transplant recipients
  • Does race influence outcomes after primary liver transplantation? A 23-year experience with 2,700 patients
  • Recurrence of hepatocellular carcinoma following liver transplantation: A review of preoperative and postoperative prognostic indicators.
  • Effectiveness of tolerability of Sirolimus in liver transplantation
  • Donor morbidity after living donation for liver transplantation
  • Efficacy and safety of low-dose tacrolimus and mycophenolate mofetil in OLT recipients
  • Impact of liver transplantation of patients with high disease severity on health care resources: University Healthsystem Consortium (UHC) Benchmarking Project.
  • ABO-Incompatible liver transplantation in the modern era

Languages Spoken

  • English, Arabic, French

Media Experience

  • KTRK Channel 13
  • Houston Culture Map

Video